Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited is a Private Indian company incorporated in 2017 and based in Gujarat, India. Senores Pharmaceuticals Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
SENORES PHARMACEUTICALS LIMITED is the legal entity of Senores Pharmaceuticals.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Senores Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +22d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +37d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Senores Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 576820374 | Axis Bank Ltd(Bank) | ₹6.47 Cr | 04 Jul 2020 | Open |
| 666758569 | Kotak Mahindra Bank Ltd(Bank) | ₹14.58 Cr | 04 Jul 2023 | Open |
| 212262466 | Kotak Mahindra Bank Ltd(Bank) | ₹24.51 Cr | 27 Jan 2019 | Open |
| 163682642 | Kotak Mahindra Bank Ltd(Bank) | ₹84.58 L | 27 Jan 2019 | Satisfied |
| 562495278 | Axis Bank Ltd(Bank) | ₹18.48 Cr | 04 Jul 2023 | Satisfied |
Charge IDs, lenders & amounts for Senores Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹47.81 Cr | ₹5.71 Cr | ₹29.84 Cr | ₹45.92 Cr | 387 |
| FY2023-24 | ₹41.76 Cr | ₹5.51 Cr | ₹15.70 Cr | ₹47.14 Cr | 268 |
| FY2022-23 | ₹41.70 Cr | ₹5.44 Cr | ₹32.49 Cr | ₹48.35 Cr | 30 |
| FY2021-22 | ₹23.27 Cr | ₹2.99 Cr | ₹18.39 Cr | ₹35.36 Cr | 200 |
Audited financials & ratios for Senores Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹47.81 Cr | ₹41.76 Cr | ₹41.70 Cr | ₹23.27 Cr |
| Other income | ₹1.17 Cr | ₹55.36 L | ₹1.24 Cr | ₹49.91 L |
| Total income | ₹48.98 Cr | ₹42.32 Cr | ₹42.94 Cr | ₹23.77 Cr |
| Total expenses | ₹41.67 Cr | ₹35.27 Cr | ₹35.97 Cr | ₹19.94 Cr |
| Profit before tax | ₹7.42 Cr | ₹7.16 Cr | ₹7.08 Cr | ₹3.89 Cr |
| Profit / (Loss) after tax | ₹5.71 Cr | ₹5.51 Cr | ₹5.44 Cr | ₹2.99 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹29.84 Cr | ₹15.70 Cr | ₹32.49 Cr | ₹18.39 Cr |
| Borrowings | ₹4.64 Cr | ₹7.45 Cr | ₹5.59 Cr | ₹6.54 Cr |
| Current liabilities | ₹6.37 Cr | ₹12.81 Cr | ₹9.19 Cr | ₹8.17 Cr |
| Total liabilities | ₹16.08 Cr | ₹31.43 Cr | ₹15.86 Cr | ₹16.97 Cr |
| Current assets | ₹19.93 Cr | ₹23.32 Cr | ₹26.12 Cr | ₹16.74 Cr |
| Cash & equivalents | ₹5.25 Cr | ₹8.42 Cr | ₹5.26 Cr | ₹4.43 Cr |
| Total assets | ₹45.92 Cr | ₹47.14 Cr | ₹48.35 Cr | ₹35.36 Cr |
| Employees | 387 | 268 | 30 | 200 |
Audited financials & ratios for Senores Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹47.81 Cr | -0.4% | +7.1% | +9.5% |
| Profit after Tax | ₹5.71 Cr | +12.7% | +1.4% | +14.4% |
| Net Worth | ₹29.84 Cr | +31.9% | +6.9% | +2.3% |
| Employees | 387 | +7.6% | +4.7% | +13.4% |
Audited financials & ratios for Senores Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹47.81 Cr | ₹5.71 Cr | +11.94% | -4.53% | +19.13% | +12.43% | 0.16 | ₹12.35 L |
| FY2023-24 | ₹41.76 Cr | ₹5.51 Cr | +13.19% | +22.67% | +35.07% | +11.68% | 0.47 | ₹15.58 L |
| FY2022-23 | ₹41.70 Cr | ₹5.44 Cr | +13.06% | +34.96% | +16.76% | +11.26% | 0.17 | ₹1.39 Cr |
| FY2021-22 | ₹23.27 Cr | ₹2.99 Cr | +12.85% | +26.45% | +16.26% | +8.46% | 0.36 | ₹11.63 L |
Audited financials & ratios for Senores Pharmaceuticals Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,55,81,675 | 78.77% |
| Institutional Investors | 2 | 17,74,722 | 5.46% |
| Public & Others | 8 | 51,21,083 | 15.77% |
Promoter, institutional & public holding for Senores Pharmaceuticals Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
248 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.